Does neuregulin-1 play a role in Type A behavior? The cardiovascular risk in young Finns study
- PMID: 18798975
- PMCID: PMC2553789
- DOI: 10.1186/1744-9081-4-40
Does neuregulin-1 play a role in Type A behavior? The cardiovascular risk in young Finns study
Abstract
Background: Neuregulin-1 proteins are related to physiological correlates of Type A in terms of cardiac reactivity. Furthermore, neuregulin-1 gene (NRG1) may play a role in cardiovascular disease such as atherosclerosis and coronary heart disease i.e. the suggested "outcomes" of Type A behavior. Therefore, NRG1 is hypothesized to be associated with Type A behavior.
Methods: The study examined whether Type A behavior pattern is associated with the single nucleotide polymorphism (SNP) SNP8NRG221533 of the NRG1. The subjects were 631 men and women participating in the population-based Cardiovascular Risk in Young Finns study in 1992 and 2001. Type A was self-assessed with the Framingham Type A Scale and reassessed nine years later.
Results: Type A was associated with NRG1 genotype. Carriers of genotype CC scored lower on Type A compared to the others.
Conclusion: Our study has pinpointed a SNP in NRG1 that predicts Type A behavior. As previous evidence suggests an association for NRG1 with beta-adrenergic stimulation, its role underlying Type A is discussed.
Similar articles
-
Association of 5' end neuregulin-1 (NRG1) gene variation with subcortical medial frontal microstructure in humans.Neuroimage. 2008 Apr 1;40(2):712-718. doi: 10.1016/j.neuroimage.2007.12.041. Epub 2008 Jan 5. Neuroimage. 2008. PMID: 18255317
-
Neuregulin genotype and medication response in Finnish patients with schizophrenia.Neuroreport. 2004 Nov 15;15(16):2517-20. doi: 10.1097/00001756-200411150-00017. Neuroreport. 2004. PMID: 15538186 Clinical Trial.
-
A functional neuregulin-1 gene variant and stressful life events: Effect on drug use in a longitudinal population-representative cohort study.J Psychopharmacol. 2017 Jan;31(1):54-61. doi: 10.1177/0269881116655979. Epub 2016 Jul 10. J Psychopharmacol. 2017. PMID: 27353026
-
Neuregulin-1, a potential therapeutic target for cardiac repair.Front Pharmacol. 2022 Aug 31;13:945206. doi: 10.3389/fphar.2022.945206. eCollection 2022. Front Pharmacol. 2022. PMID: 36120374 Free PMC article. Review.
-
Proteolytic processing of Neuregulin-1.Brain Res Bull. 2016 Sep;126(Pt 2):178-182. doi: 10.1016/j.brainresbull.2016.07.003. Epub 2016 Jul 5. Brain Res Bull. 2016. PMID: 27393467 Review.
References
-
- Friedman M, Rosenman RH. Association of specific overt behavior pattern with blood and cardiovascular findings; blood cholesterol level, blood clotting time, incidence or arcus senilis, and clinical coronary artery disease. J Am Med Assoc. 1959;169:1286–1296. - PubMed
-
- The review panel on coronary-prone behavior and coronary heart disease Coronary-prone behavior and coronary heart disease: a critical review. Circulation. 1981;63:1199–1215. - PubMed
-
- Shekelle RB, Hulley SB, Neaton JD, Billings JH, Borhani NO, Gerace TA, Jacobs DR, Lasser NL, Mittlemark MB, Stamler J. The MRFIT behavior pattern study. II. Type A behavior and incidence of coronary heart disease. Am J Epidemiol. 1985;122:559–570. - PubMed
-
- Keltikangas-Järvinen L, Hintsa T, Kivimäki M, Puttonen S, Juonala M, Viikari JS, Raitakari OT. Type A eagerness-energy across developmental periods predicts adulthood carotid intima-media thickness: the Cardiovascular Risk in Young Finns Study. Arterioscler Thromb Vasc Biol. 2007;27:1638–1644. doi: 10.1161/ATVBAHA.107.145524. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Research Materials